Viewing Study NCT07064902


Ignite Creation Date: 2025-12-25 @ 4:03 AM
Ignite Modification Date: 2025-12-26 @ 2:57 AM
Study NCT ID: NCT07064902
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-18
First Post: 2025-07-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma
Sponsor: Sun Yat-sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Nasopharyngeal Carcinoma (NPC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PD-1/VEGF bispecific antibody View
None Chemoradiotherapy View
None Anti-PD-1 Therapy View
None Ivonescimab View
None Immunotherapy View
None Bispecific Antibody View